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Palavras-Chave  
 
 
Vidros, Vitro-cerâmicos, Biomateriais, Sinterização, Cristalização. 
Resumo 
 
 
Os vidros e vitro-cerâmicos do sistema ternário diopsite (CaO·MgO·2SiO2; 
posteriormente mencionado como Di) – fluorapatite (9CaO·3P2O5·CaF2; 
posteriormente mencionado como FA) e fosfato tricálcico (3CaO·P2O5; 
posteriormente mencionado como TCP) são potenciais candidatos para várias 
aplicações biomédicas incluindo estruturas de suporte para engenharia de 
tecido ósseo.  
O presente trabalho teve como objectivo investigar os vidros e os vitro-
cerâmicos do sistema Di-FA-TCP quanto à sua estrutura e capacidades de 
formação, sinterização e cristalização. Estudou-se também a influência da 
variação das razões SrO/CaO e ZnO/MgO na estrutura e em várias 
propriedades termo-físicas nos mesmos vidros, nos quais o CaO foi 
parcialmente substituído pelo SrO e o MgO pelo ZnO (0-10 mol.%). Todos os 
vidros estudados foram preparados pela técnica de fusão-arrefecimento rápido. 
A análise estrutural dos vidros foi feita por Ressonância Magnética Nuclear 29Si 
e 31P (NMR) e Espectroscopia de Infra-Vermelho (FTIR). Em todos os vidros a 
rede de silicato é coordenada predominantemente nas unidades Q2 (Si) 
enquanto que o fósforo tende a permanecer no ambiente do ortofosfato (Q0). O 
comportamento dos pós dos vidros na sinterização e cristalização foi estudado 
por Microscopia de Aquecimento (Hot Stage Microscopy - HSM) e por Análise 
Térmica Diferencial (DTA), respectivamente, enquanto a evolução das fases 
cristalinas e da microestrutura dos vitro-cerâmicos foi seguida por Difracção de 
Raios-X (XRD) e por Microscopia Electrónica de Varrimento (SEM). Na maioria 
das composições dos vidros investigados, a sinterização precedeu a 
cristalização tendo a DI e a FA cristalizado como fases primárias em todos os 
vitro-cerâmicos após sinterização a 850ºC durante 1 h.     
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abstract 
 
The glasses and glass-ceramics in ternary system of diopside 
(CaO·MgO·2SiO2; hereafter referred as Di) – fluorapatite [9CaO·3P2O5·CaF2; 
hereafter referred as FA] – tricalcium phosphate (3CaO·P2O5; hereafter 
referred as TCP) system are potential candidates for various biomedical 
applications including scaffolds for bone tissue engineering. The present work 
investigates the glass forming ability, structure, sintering ability and 
crystallization behaviour of some glasses along Di-FA-TCP join. Further, 
influence of varying SrO/CaO and ZnO/MgO ratio has been studied on 
structure and various thermo-physical properties of glasses in the above 
mentioned system where CaO has been partially substituted by SrO and MgO  
has been partially substituted by ZnO (0 – 10 mol.%). All the glasses have 
been prepared by melt-quenching technique. The structural analysis of glasses 
has been made by 29Si and 31P-nuclear magnetic resonance (NMR) and 
infrared spectroscopy (FTIR). The silicate network in all the investigated 
glasses is predominantly coordinated in Q2 (Si) units while phosphorus tends to 
remain in orthophosphate (Q0) environment. The sintering and crystallization 
behaviour of glass powders has been studied by hot stage microscopy (HSM) 
and by differential thermal analysis (DTA), respectively while crystalline phase 
evolution and microstructure of glass-ceramics has been followed by X-ray 
diffraction (XRD) and scanning electron microscopy (SEM). The sintering 
preceded crystallization in majority of the glass compositions and Di and FA 
crystallized as the primary crystalline phases in all the investigated glass-
ceramics after sintering at 850ºC for 1 h.  
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Chapter 1 
State Of the Art 
 
 
 
 
 
 
 1 
1. Introduction 
 
1.1 Glasses and Glass Ceramics 
Science and technology in today’s era constantly requires new materials with 
special properties to achieve breathtaking innovations. This development centres on the 
improvement of scientific and technological fabrication and working procedures. 
Glasses and glass-ceramics are one such category of materials. A glass can be defined 
as an amorphous solid completely lacking in long range, periodic atomic structure, and 
exhibiting a region of glass transformation behaviour.  Any material, inorganic, organic, 
or metallic formed by any technique, which exhibits glass transformation behaviour is 
considered to be a glass [1]. Glasses may be prepared by various techniques, for 
example: conventional melt-quenching technique, sol-gel synthesis, vapour deposition, 
neutron irradiation of crystalline materials, etc. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1. Glass-ceramic prepared by controlled nucleation and crystallization of bulk 
glass. 
 
  The glass-ceramics are ceramic materials formed either through the controlled 
nucleation and crystallization of bulk glasses (Fig. 1.1) or obtained by sintering and 
crystallization of glass powder compacts (Fig. 1.2). These materials offer the possibility 
of combining the special properties of conventional sintered ceramics with distinctive 
characteristics of glasses. It is however, possible to develop modern glass-ceramic 
materials with features unknown, thus far, in either ceramics or glasses or in other 
materials such as metals or organic polymers. 
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Fig. 1.2. Glass-ceramics synthesized by sintering and crystallization of glass powder 
compacts. 
 
 
The major advantage of glasses and glass-ceramics above their ceramic 
counterparts is their ability to accommodate various functional ions in their amorphous 
or crystalline phase, thus providing the flexibility to tailor and optimize their 
compositions with respect to different technological applications [2]. 
  
The silicate and phosphosilicate based bioactive glasses and glass-ceramics are 
potential materials for the development of porous scaffolds for bone tissue engineering 
[3-8]. Bioactive glasses and glass-ceramics are a class of bioactive materials, i.e. 
materials which elicit a special response on their surface when in contact with biological 
fluids, leading to strong bonding to living tissue. In the field of bone engineering, 
bioactivity is defined as the ability of the material to bond to bone tissue via the 
formation of a bone-like hydroxyapatite layer on its surface [4]. Due to a number of 
attractive properties for use in tissue engineering and regeneration, there is increasing 
effort in the use of bioactive glasses and glass-ceramics in tissue engineering 
applications.  
 
In tissue engineering, a highly porous artificial extracellular matrix or scaffold is 
required to accommodate mammalian cells and guide their growth in tissue regeneration 
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in three dimensions (3D). However, existing 3D scaffolds for tissue engineering proved 
less than ideal for actual applications as there are numerous challenges being faced by 
these synthetic implants in terms of selection of scaffold materials, mechanical strength, 
biodegradability, interconnection channels, etc. In the light of the above mentioned 
perspective, the primary aim of this work is to design and develop potentially bioactive 
glass-ceramics in the diopside (CaMgSi2O6; here after referred as Di))-fluorapatite 
[Ca5(PO4)3F; here after referred as FAp] - tricalcium phosphate (3CaO·P2O5; here after 
referred as TCP) system and gain fundamental knowledge about their structure, 
sintering and crystallization behaviour. Further, owing to beneficial aspects of strontium 
and zinc in human biomedicine, an attempt has been made to study the influence of SrO 
and ZnO on the various structural and thermo-physical properties of glasses in the 
parent Di-FA-TCP system. 
 
1.2. Selection of scaffold material 
Critical-size bone defects often result from trauma or tumours and can not be 
repaired by body. Also, due to the increased mean population age and to ever more 
surgery being undertaken to remove tumours, bone regeneration is a clinical need of 
growing importance [9]. Autografts, allografts or xenografts can be used as bone 
substitutes. However, these techniques have insurmountable drawbacks associated with 
them. For example: autologous bone grafts, though still considered to be gold standard 
due to their ability to support osteoinduction and osteogenesis, suffer from the need for 
further surgery and to donor site morbidity. Similarly, allografts and xenografts are 
known to exhibit poorer bone induction properties in comparison to autografts and can 
also be accompanied with non-negligible risk of contamination, immune rejection or 
viral transmission from donor [10]. It is due to these reasons that a paradigm shift is 
taking place in medicine from using synthetic implants and tissue grafts to a tissue 
engineering approach that uses porous material scaffolds integrated with biological cells 
or molecules to regenerate tissues [11]. The underlying concept of TE is the belief that 
cells can be isolated from a patient, and its population then expanded in a cell culture 
and seeded onto a carrier. The resulting TE construct is then grafted back into the same 
patient to function as the introduced replacement tissue. Since, many isolated cell 
populations can be expanded in vitro using cell culture techniques, only a very small 
number of donor cells may be needed to prepare such implants [11]. Therefore, this new 
paradigm requires scaffolds that balance temporary mechanical function with mass 
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transport to aid biological delivery and tissue regeneration in three dimensions (3D) 
[12]. 
There are several requirements in the design of scaffolds for TE. Many of these 
requirements are complex and not yet fully understood. However, the first and foremost 
issue with regard to scaffold development is the choice of suitable material. The 
desirable characteristics of these materials are biocompatibility (i.e. not to provoke any 
unwanted tissue response to the implant and at the same time to possess the right 
surface chemistry to promote cell attachment and function), biodegradability (i.e. 
degradable into non-toxic products, leaving the desired living tissues) [17] and 
mechanical properties (i.e. the scaffold should have mechanical strength needed for the 
creation of macroporous scaffold that will retain its structure after implantation, 
particularly in the reconstruction of hard, load-bearing tissues  such as bone and 
cartilage). 
In terms of scaffold material, bioactive glass-ceramics are particularly attractive 
for bone tissue engineering as they form a direct physical bond to bone via the 
formation of an apatite layer on the surface of material [19]. The glass-ceramic materials 
are produced by a so called "controlled crystallization" in glasses and are characterized 
by the presence of an amorphous phase and one or more crystalline phases. Also, glass-
ceramics usually exhibit superior properties in comparison to their parent glasses and 
sintered crystalline ceramics. Further, different kinds of silicate-based bioactive glass-
ceramics have been developed [10, 18-20] based on the fact that glass based materials 
offer flexibility to tailor their compositions in accordance with the desired properties by 
allowing greater control over their atomic/molecular structure. Among all the 
investigated silicate based bioactive glass-ceramic compositions as reported in literature 
so far, apatite-wollastonite (A/W) glass-ceramic (CERABONE® A-W), as developed by 
Kokubo et al [19], along the pseudo ternary system 3CaO·P2O5 - CaO·SiO2 - 
MgO·CaO·2SiO2 and comprising of 38 wt.% apatite [Ca10(PO4)6(O, F2)], 24 wt.% 
wollastonite (hereafter referred as W; CaSiO3) and 28 wt.% residual glassy phase, is the 
most widely and successfully used bioactive glass-ceramic for bone replacement in 
human medicine. The glass-ceramic exhibits particularly high bioactivity, good 
mechanical strength (flexural strength: 215 MPa and Young’s modulus: 118 GPa), and 
demonstrates the ability to be machined in various shapes [20]. Further, since 1983, this 
glass-ceramic has been successfully used in spine and hip surgeries of patients with 
extensive lesions and bone defects [13]. It is due to these reasons that even after more 
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than 3 decades of its discovery; A/W glass-ceramic still enjoys an immense attention 
from the scientific community working in the area of biomaterials owing to its ever 
increasing potential applications in biomedicine. However, even though, A/W glass-
ceramic possess the highest mechanical strength among all the bioceramics developed 
so far, the glass-ceramic scaffolds derived from this composition still can not be used in 
load-bearing applications [14]. Also, there are questions raised related to the long term 
effect of silica [15], and slow degradation of this glass-ceramic, often taking some years 
to disappear from the body [16]. The slow degradation of glass-ceramic scaffold may 
lead to reduction in its effective pore size by in vivo events such as the invasion of 
fibrous tissue into the pores and the non-specific adsorption of proteins onto the 
material’s surface. 
Another approach towards development of materials with good bioactivity as 
well as biodegradability is phosphate based bioactive glass-ceramics [21]. Calcium 
phosphate glass-based materials have high potential for use as biomaterials because 
their chemical composition is close to that of hard tissues. These glass-ceramics are 
known to exhibit excellent bioactivity as well as biodegradation behaviour [21]. 
However, the major disadvantage of calcium-phosphate glass-ceramics is their poor 
mechanical strength. Although, the mechanical strength of glass-ceramics is higher in 
comparison to their parent glasses, nevertheless, while using calcium phosphate crystals 
as dental and bone material, there are cases where further improved strength is required 
[22]. Therefore, still there is a dearth for an effective bioceramic which can exhibit 
equilibrium amid their mechanical function and mass transport. 
 A feasible solution to overcome the serious limitations posed by both silicate as 
well as phosphate based glass-ceramics lies in the development of novel high strength 
glass-ceramic compositions with excellent bioactivity and biodegradability by mixing of 
a mechanically strong silicate based bioactive crystalline material with calcium-
phosphate based biodegradable crystalline material. In this pursuit, glass-ceramics along 
Di – FAp – TCP join are potential candidates to be explored towards development of 
high strength biodegradable glass-ceramic scaffolds due to their salient features as 
described below.  
Diopside (Di) belongs to the group of inosilicates and it is one of the important 
member of the clinopyroxene group with the composition CaMgSi2O6. The structure of 
Di consists of chains of SiO3 held together by magnesium in octahedral sites, and 
calcium in eight-coordinated sites. Glasses and glass ceramics synthesized through this 
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Di composition have been investigated and studied by researchers for various properties 
and mechanisms mainly due to their wide potential and for practical applications.  
Di based ceramics and glass-ceramics have generated enough interest among the 
material scientists and mineralogists due to their potential application as bioactive 
materials. It has been revealed that Di has no general toxicity in cell culture and it helps 
in bone regeneration. Aza et al. [23] investigated the behaviour of the material in a 
natural medium of high protein content by soaking Di based ceramic pellets in human 
parotid saliva (HPS) over various time intervals. The results showed the formation of 
HAp like layer on the surface of the ceramic, and also suggested that the mechanism of 
HAp layer formation in saliva was similar to that showed in vitro tests by other silica-
based materials. Yogananad et al. [24] with Di as the major crystalline phase and with 
the help of transferred arc plasma technique in the system CaO-MgO-SiO2 synthesized 
bioactive GCs. Formation of HAp on the glass-ceramic surface has been observed after 
12 days of immersion in simulated body fluid (SBF). Fibroblast culture also results in 
showing that Di-glass-ceramics were non-toxic to human fibroblasts and promote cell 
growth.  
Apart from the above discussed biocompatibility aspect of diopside based 
ceramics and glass-ceramics; they are known to exhibit superior mechanical properties 
in comparison to many of their ceramic counterparts. For example: Nonami and 
Tsutsumi [25] increased the fracture toughness of pure sintered hydroxyapatite (Hap) to 
fabricate a composite of Di and HAp. It was reported that the bending strength and 
fracture toughness of Di-Hap composite is 2 to 3 times higher in comparison to the 
sintered HAp. Also, diopside based glass-ceramics exhibit considerably higher 
mechanical strength in comparison to their wollastonite (CaO·SiO2; hereafter referred as 
W) based counterparts [26] Therefore, owing to the presence of Di we can expect 
superior mechanical properties for Di-FAp-TCP GCs without compromising their 
biomedical characteristics. 
Further, presence of hydroxy-, oxy- or FAp as one of the crystalline phases in 
the scaffold material is highly beneficial for its final biomedical applications. In 
particular, during last two decades, FAp based glass-ceramics have gained considerably 
higher attention due to their structural and chemical similarities with bone forming 
mineral, HAp [Ca5(PO4)3OH] [27] along with their higher stability in comparison to 
latter [28]. Also, the fluoride is known to increase bone density due to which fluoride 
releasing implants might of interest for patients suffering from osteoporosis [20]. The 
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binary system along Di-FAp join is characterized by the absence of any binary 
compounds and no positive evidence of the presence of solid solutions as depicted by 
Kogarko [29] and later by Tulyaganov [30]. The glass-ceramics along Di-FAp join were 
developed by Hobo and Takoe [31] with the objective of producing biomaterials for 
restorative dental applications under the commercial name of Cerapearl®. Also, Shibuya 
et al. [32] developed non-alkali containing Di-FAp-W bioactive glass-ceramics for 
replacement materials for tooth roots, dental crowns and bones while Tulyaganov et al. 
[33] developed glass-ceramics in ternary system tetrasilicic mica-FAp-Di. Recently, 
Salman et al. [34] studied the in vitro bioactivity of Di–FAp–W–sodium silicate-based 
glass-ceramics by immersion in simulated body fluid solution. The as-prepared and 
investigated GCs exhibited excellent bioactivity and were proposed to be suitable for 
restorative dental and bone implants materials. 
Similar to Di-FAp join, the glass-ceramics along Di-TCP join have been a 
subject of interest due to their potential biomedical applications. TCP is a typical 
bioresorbable material and is already used clinically as an important bone-repair 
material [35]. However, the major concern with the application of TCP is its high 
degradation rate which makes difficult to control its bone-bonding ability and 
bioresorbability. It is due to this reason that Kamitakahara et al. [36] synthesized glass-
ceramics along Di-TCP join as it was anticipated that a GC containing Di and TCP 
would produce materials with excellent bioactivity and high mechanical strength during 
initial stages after implantation, followed by appropriate degradation during bone 
regeneration. In another study, Ashizuka et al. [37] reported the flexural strength of 
eutectic GC composition 38 TCP · 62 Di (wt.%) to be higher than 200 MPa.  
Despite the very interesting studies reported in literature related with glass-
ceramics in Di-FAp and Di-TCP system, respectively, literature survey reveals that no 
study in particular dealing with the development of high strength biodegradable glass-
ceramics in ternary system Di-FAp-TCP system has been documented in literature so 
far.  
Apart from the above-discussed salient features of glass-ceramics in Di-FAp-
TCP system, another positive trait of these glass-ceramics is the presence of glassy 
phase which provides them flexibility to accommodate various functional ions (for 
example: Sr, Zn, Ag, Cu, etc.) in desired amounts, a severe limitation usually faced by 
crystalline ceramics. These ionic substitutions play a vital role in deciding the biological 
behaviour of the materials as they have the ability to tailor the biological properties of 
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materials with respect to their target oriented applications [38]. Therefore, second aim 
of our research work is to study the influence of strontium and zinc doping on structure 
and thermophysical properties of glasses in the above discussed parent system. 
    
1.3 Role of strontium in human biomedicine 
Studies to investigate the influence of Sr2+ (Strontium) functional ions were 
performed along the previous century and had created a great zeal of interest by the 
researchers across the globe. Interesting and intriguing studies were done and performed 
successively by various scientist and research professionals with respect to the 
strontium ions. Investigations over strontium and its influences took different dimension 
over the period of time and with respect to the interest of study and applications. Role of 
strontium, which is considered to be one of the predominant alkaline earth element 
found to play a vital role biologically, chemically, physically, mechanically and takes 
various other roots with relevancy to its area of study and implementation period. 
Strontium is being studied extensively for its bioactivity and biodegradability because 
of its bone forming abilities.  
Shorr and Carter [39] were the pioneers to suggest that Sr might be useful for 
osteoporosis while McCaslin and Janes [40] conducted research on individuals suffering 
from osteoporosis using strontium ranelate and ended up with astounding results of 
bringing out 78% increase in the bone mass and the bone formation showed an increase 
rate of 172%. Successive to these studies, strontium lactate became one of the major 
and preliminary elements for in vivo studies. Similarly, in 1981, Skoryna et al. [41] 
tested strontium gluconate on patients having breast cancer and bone cancer. With a 
dose of 274-mg/day new mineral deposits were absorbed which used to be noticed with 
600 to 700 mg/day in the previous studies. It was concluded that strontium gluconate 
was absorbed more readily than the previously used strontium carbonate.  
 In 2004 Nielsen et al. [42] reviewed the biological role of strontium and 
principally pointed out the differences and similarities of calcium and magnesium over 
strontium, which had been brought in focus by other authors over the years. It is the 
most comprehensive review, which summarizes information related with strontium 
toxicity, homeostasis, and mobility across the membranes (in animals and in humans 
too), Ca-Sr interactions and specifically its role in the formation of bones has been 
categorized.  
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With respect to Sr-containing bioactive glasses, Lao et al. [43] synthesized 
glasses in SiO2-CaO-SrO system through sol-gel method. The results pertaining to in 
vitro bioactivity analysis of the as developed glasses exhibited their strong potential 
towards osteoporosis treatment, dental applications and in bone tissue regeneration as 
well in bone remodelling. Further, substituting strontium ions in place of calcium, 
magnesium and to other alkaline earth cations showed good results in terms of 
bioactivity which sometimes claimed to be most challenging and also witnessed some 
phenomenal exchange of ideas and outcome which kindled the research of Sr-doped 
glasses with respect to the bone tissue engineering. For example, influence of doping Sr 
for Ca on the structure of bioactive alkali-phosphosilicate glasses and its influence on 
the nucleation and crystallisation behaviour has been investigated [44]. Sr2+ is known to 
behave in a comparable way to Ca2+. The role Sr2+ in the bone resorption and 
metabolism in the history of bone tissue engineering has been well documented [45-47].  
 
1.4 Zinc as a doping element 
 
Zinc being one of the major chemical elements acts as an integral part in the 
growth of humans and animals. In bone formation, resorption and tissue engineering 
zinc plays a vital and significant role as per studies and research. Retardation in the 
bone formation or growth is a common finding, which is related with the deficiency of 
zinc, thus demonstrating the important role of zinc in the bone metabolism [48]. Over 
the years, a large number of experiments have been conducted over the influence of zinc 
in the regulation of bone metabolism. Zinc compounds, including nutritional, 
pharmacological and physiological products revealed to be very useful in the prevention 
of bone loss due to osteoporosis [49]. 
 
1.5 Zinc in human and animal biomedicine 
 
Similarly to strontium, zinc also plays an innumerable importance in human and 
animal biomedicine. Hurley [50] reviewed the changes and developments happening in 
the bone and skeletal system of the human body due to the deficiency of zinc ion. 
Skeletal defects occurring during the bone development due to zinc deficiency in case 
of animals for example pigs, monkeys, cows, rats, etc., has also been reported by Hurley 
[50]. Masayoshi [51] has reviewed the role of zinc in bone formation and in bone 
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resorption. Masayoshi apart from bone metabolism further reviewed the role of zinc in 
the osteoblastic cells and in osteoporosis. With other critical studies he also concluded 
that many kinds of skeletal abnormalities in fatal and postnatal development were 
related with zinc deficiency.  
 
Baron et al. [52] reviewed that the presence of the major cells in the bone tissue, 
osteoblasts and osteoclasts regulates the metabolism of bone. Similarly, many review 
articles were devoted to the regulation of bone cells. The reviews of Canalis et al., [53] 
Mohan and Baylink [54] Masayoshi and Takahashi [55] were specifically focussed on 
the bone cells and influence of zinc over those bone cells. Atsuo et al. [56] suggested 
that the Zinc-containing tricalcium phosphate (ZnTCP) could be used as a 
pharmaceutical product for promoting bone formation. Both in vivo and in vitro studies 
revealed that Zinc as an essential trace element has stimulatory effects on bone 
formation [56]. The experimental study of Xia et al. [57] aimed at developing a calcium 
phosphate cement (bone forming mineral) containing α-tricalcium phosphate (αZnTCP) 
and then studying its in vivo behaviour as a bone graft material. The influences of 
αZnTCP in hardened bodies through in vivo studies were explored. Through this 
experimental study it was later concluded that hardened body prepared with αZnTCP 
with the release of zinc ions found to be superior to that prepared with αTCP in 
promoting new bone formation.  
 
Calhoun et al. [58] studied the effect of dietary zinc deficiency in ectopic bone 
formation. Various studies have been conducted and rats were used for the same. Based 
on the results obtained, they strongly suggested that zinc plays an active role in bone 
metabolism. Similarly, Akifumi et al. [59] investigated the various effects of zinc on 
bone metabolism and tooth formation through in vivo studies using organ cultures of 
calvaria, tooth germ, and cell cultures of osteoblastic cells. The results of this 
investigation indicated that influence of zinc increases the alkaline phosphatase (ALP) 
activity in the bone without affecting any change in the enzyme synthesize and further 
inhibits the bone mineralization, which was subjected to 4, 7 and 25 days of in vivo 
studies.   
 
Kamitakahara et al. [60] studied the effect of bioactive glass-ceramics containing 
apatite (A) and wollastonite (W) with the addition of ZnO. Generally, glass ceramics 
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containing A-W show high bone bonding ability (bioactivity) with high mechanical 
strength. So in this study of doping A-W bioactive glass ceramics with ZnO may 
provide CaO–SiO2–P2O5–CaF2 glass–ceramics enhances the new bone formation with 
appropriate biodegradation as well. Zreiqat et al. [61] developed calcium-silicon 
ceramic scaffolds for bone tissue engineering incorporating strontium along with zinc to 
form Sr–Hardystonite (Sr-HT). The physical and biological properties of Sr–HT are 
studied and compared over Hardystonite(HT). Sr-HT scaffolds are found to be porous 
(interconnectivity: 99%) with large pore size (300–500 µm) with relatively high 
compressive strength (2.16 ± 0.52 MPa) than that of HT, which enhances the bone 
ingrowth in load bearing applications.  Further, in vivo osteoconductivity of the 
developed Sr-HT and HT scaffolds was assessed at 3 and 6 weeks followed by 
implantation in tibial bone defects in rats. Microscopic studies revealed the rapid new 
bone growth formation into the pores of the 3D scaffolds with the Sr–HT and HT, 
relative in comparison to the β-tricalcium phosphate (β-TCP).  
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Chapter 2 
Experimental Procedure 
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2.1 Glass synthesis 
Powders of high purity standards and such as SiO2, CaCO3, MgCO3, NH6P2O5, 
CaF2, SrCO3 and Bi2O3 were utilized for the preparation of the required phospho-
silicate glass. Homogeneous mixtures of batches of approximately 100 g each were 
prepared by ball milling according to the planned compositions. After ball milling, the 
batches obtained were then calcined at 900ºC for 1 h for decarbonisation and then 
melted in a platinum crucible at the temperature of 1550ºC for 1 h, in air. Glasses in 
both bulk (Fig. 2.1) and frit forms (Fig. 2.2) were obtained.  
 
 
 
 
 
 
 
 
 
Fig. 2.1 Bulk glass 
The bulk glasses were produced by pouring the melts on the preheated bronze plates and 
then further subjecting them to annealing at 500 ºC for 1 h, depending greatly on the glass 
composition. Similarly, the frit form of glasses was obtained the quenching the glass 
melts in cold water. The frits (Fig. 2.2) were dried and then milled in a high-speed agate 
mill for 45 minutes to obtain fine glass powders that were then fractionated in a 63 µm 
sieve. 
 
 
 
 
 
 
 
 
Fig. 2.2. Glass frits 
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 The compositions in weight percent (wt.%) of strontium (Sr) and Zinc (Zn) 
containing glasses are reported in Table. 2.1.1. The melt quenching technique (Fig. 2.3.) 
was used for the preparation of the glass through this technique we obtain both the 
forms of glass i.e. glass frits and glass bulk. 
Table 2.1.1. Compositions (wt.%) of the Sr & Zn Series of glasses. 
Glass MgO CaO SrO(ZnO) P2O5 SiO2 CaF2 
Sr-2 19.24 34.07 2 5.61 38.49 0.59 
Sr-4 19.24 32.07 4 5.61 38.49 0.59 
Sr-6 19.24 30.07 6 5.61 38.49 0.59 
Sr-8 19.24 28.07 8 5.61 38.49 0.59 
Sr-10 19.24 26.07 10 5.61 38.49 0.59 
Zn-2 17.24 36.07 2 5.61 38.49 0.59 
Zn-4 15.24 36.07 4 5.61 38.49 0.59 
Zn-6 13.24 36.07 6 5.61 38.49 0.59 
Zn-8 11.24 36.07 8 5.61 38.49 0.59 
Zn-10 9.24 36.07 10 5.61 38.49 0.59 
 
After quenching (Fig. 2.4), the glass frit was removed from the water before 
allowing it to leach, while the bulk glass was subjected to annealing to remove the 
internal stresses from the glass. The Glass frits removed from the water were then dried 
in an 80ºC oven. 
 
 
 
 
 
 
 
 
Fig. 2.3. Glass melting furnace 
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Fig. 2.4. Melt-Quenching technique 
  
The bulk glass after annealing was cut and grinded into small samples of 
approximate size, which were then subjected to dilatometry tests to study the expansion 
and thermal properties of the Sr and Zn glasses. The dried glass frits were then milled 
for 2 to 3 minutes in a planetary ball mill (reference of the equipment) at about 200 rpm 
(revolutions per minute). Each milled glass frit was then passed through a sieve of 300-
425 µm to obtain about 5 to 6 g of this relatively coarse powder and the remaining glass 
frit was milled for further 45 minutes at the same 200 rpm setting and then passed 
through a sieve of 63 µm. 
 
2.2 Preparation of glass ceramics 
Glass ceramics can be prepared either by nucleation and crystallization through 
suitable heat treatments given to monolithic glasses, or by sintering and crystallization 
of glass powder compacts (GPCs). Rectangular bars with dimensions 4 x 5 x 50 mm3 
and circular disc shaped pellets with Ø20 mm and thickness ~3 mm were prepared from 
fine glass powders by uniaxial pressing (80 MPa). The GPCs were sintered under 
isothermal conditions for 1 h at the temperature of 850ºC. A slow heating rate (ß) of 2 
K/min was maintained in order to prevent deformation of the samples.  
 
2.3 Characterization of glasses 
2.3.1 Amorphous nature and liquid-liquid phase separation in glasses 
The amorphous nature of glasses was confirmed by x-ray diffraction (XRD) and 
scanning electron microscopy (SEM). In order to examine the possibility of existence of 
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liquid-liquid amorphous phase separation, glasses in bulk form were heat-treated 850ºC 
for 1 h at heating rate of 5 K/min and were observed under SEM.  
 
2.3.2 Structural characterization of glasses  
Infrared spectroscopy (FTIR)  
FT-IR stands for Fourier Transform Infrared Spectroscopy. FTIR provides 
information about the chemical bonding or molecular structure of materials, whether 
organic or inorganic. It is used to identify unknown materials present in a specimen, and 
is usually conducted to complement EDX analysis. This method of experimentation 
works on the principle of bonds and groups of bonds vibrate at characteristic 
frequencies. A molecule that is exposed to infrared rays absorbs infrared energy at 
frequencies, which are characteristic to that molecule. During the experiments and 
analysis, a spot on the specimen is subjected to a modulated IR beam. The reflectance of 
the infrared rays and specimen’s transmittance at different frequencies is translated into 
an IR absorption plot which comprises of reverse peaks. The resulting FTIR spectral 
pattern is then analyzed and matched with known signatures of identified materials in 
the FTIR library. Apart from the above-mentioned qualitative analysis, FTIR technique 
can also be subjected to quantitative analysis. The following Fig. 2.5 shows the set up of 
a FT-IR experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.5. View of a FTIR equipment 
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In infrared spectroscopy, infrared light passes through the sample and certain 
frequencies of the light are absorbed by the chemical bonds of the substance, leading to 
molecular vibrations and these vibrations creates the molecular fingerprint of the 
sample. Similar to our fingerprint, no two molecular structures of the sample produce 
the same infrared spectrum [62]. This makes this technique very unique to characterize 
the structural morphology of glasses. In order to obtain good quality spectra, the 
samples were crushed in an agate mortar to obtain particles of micrometer size. This 
procedure was applied every time to the fragments of bulk glass in order to avoid the 
structural modifications due to ambient moisture [63]. Infrared spectra for the glass 
powders were obtained using an infrared Fourier spectrometer (FT-IR, model Mattson 
Galaxy S-7000, USA). For this purpose each sample was mixed with KBr in the 
preparation of 1/150 (by weight) for 15 min and pressed into a pellet using a hand press.  
 
Magic angle spinning-Nuclear magnetic resonance (MAS-NMR) 
 
The 29Si MAS NMR spectra were recorded on a Bruker ASX 400 spectrometer 
operating at 79.52 MHz (9.4 T) using a 7 mm probe at a spinning rate of 5 kHz. The 
pulse length was 2 µs and 60 seconds delay time was used. Kaolinite was used as the 
chemical shift reference. The 31P MAS NMR spectra of glasses were recorded on a 
Bruker ASX 400 spectrometer operating at 161.97 MHz with 45 pulses, spinning rates 
of 12 kHz, a 60 s recycle delay and the chemical shift is quoted in ppm from phosphoric 
acid (85%). 
2.3.3 Density and molar volume 
 
The apparent density of glasses as well as glass-ceramics was measured by 
Archimedes principle by immersion of monolithic samples in ethylene glycol. The 
density was calculated in accordance with the following equation: 
l
la
a
WW
W
!! "
#
=   (1) 
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where, ρ is the apparent density of glass/glass-ceramic while Wa corresponds to the 
weight of sample in air, Wl corresponds to the weight of sample in liquid, i.e., ethylene 
glycol, and ρl refers to the density of liquid (density of ethylene glycol: 1.113 g cm-3). 
Further, the molar volume (Vm) of glasses was calculated using the following equation: 
!
M
V
m
=   (2) 
where M is the molar mass of the glass and ρ is its apparent density. 
 
2.3.4 Thermal Analysis 
 
Dilatometry 
 
Dilatometry measurements were done with prismatic samples with cross section 
of 4 x 5 mm2 (Bahr Thermo Analyse DIL 801 L, Hullhorst, Germany GmbH; heating 
rate 5 K/min). The mean values and the standard deviations (SD) presented for 
coefficient of thermal expansion (CTE) (for all glass series), have been obtained from 
five different samples for each glass series. 
 
Differential Thermal Analysis (DTA) 
 
The differential thermal analysis (DTA-TG, Setaram Labsys, Setaram 
Instrumentation, Caluire, France) of glass powders was carried out in air from room 
temperature to 1000°C at heating rate (β) of 5 K min−1. The glass powders (mean 
particle size: 10–20 µm) weighing 50 mg were contained in an alumina crucible and the 
reference material was α-alumina powder.  
 
Hot stage microscopy 
 
A side view hot stage microscope (HSM) EM 201 equipped with image analysis 
system and electrical furnace 1750/15 Leica was used. The microscope projects the 
image of the sample through quartz window and onto the recording device. The 
computerized image analysis system automatically records and analyzes the geometry 
changes of the sample during heating. The image analyzer takes into account the 
thermal expansion of the alumina substrate while measuring the height of the sample 
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during firing, with the base as a reference. The HSM software calculates the percentage 
of decrease in height, width and area of the sample images. The measurements were 
conducted in air with a heating rate of 5 K/min. The cylindrical shaped samples with 
height and diameter of ~3 mm were prepared by cold-pressing the glass powders. The 
cylindrical samples were placed on a 10 x 5 x 1 mm alumina (>99.5 wt.% Al2O3) 
support. The temperature was measured with a Pt/Rh (6/30) thermocouple contacted 
under the alumina support. The temperatures corresponding to the characteristic 
viscosity points (first shrinkage, maximum shrinkage, softening, half ball and flow) 
were obtained from the photographs taken during the hot-stage microscopy experiment 
following Scholze´s definition (defines the viscosity-temperature relationships during 
the sintering of glass powders) [64, 65]. 
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Chapter 3 
Results and Discussion 
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3.1 Glasses and glass-ceramics along diopside (CaMgSi2O6)- fluorapatite 
[Ca5(PO4)3F]- tricalcium phosphate (3CaO·P2O5)  
 
3.1.1. Design of the parent glass compositions  
 The glasses were designed in the ternary system of Di-FA-TCP with varying 
Di/TCP ratio while maintaining FA to be constant. The nominal composition of the 
studied glasses varied between (90-x) Di – 10 FA – x TCP (x = 10 - 40 wt.%). The 
detailed composition of the glasses has been presented in Table. 3.1.1. The addition of 
FA was made considering the fact that fluoride releasing implants and FA in itself has 
numerous beneficial traits that can be utilized in dental as well as orthopaedics as has 
also been discussed in chapter 2.  However, amount of FA in glasses was chosen to be 
low as higher amount of fluoride in glasses decreases their reactivity with body fluids 
due to its corrosion inhibiting effect [66].  
 
Table 3.1.1. Compositions (wt.%) of the parent glasses 
Glass MgO CaO P2O5 SiO2 CaF2 
TCP-10 21.29 32.00 3.57 42.57 0.57 
TCP-20 19.24 36.07 5.61 38.49 0.59 
TCP-30 17.06 40.42 7.79 34.12 0.61 
TCP-40 14.72 45.08 10.12 29.45 0.63 
 
3.1.2 Glass forming ability 
Among all the investigated compositions, we could obtain monolithic true glasses 
only from compositions with TCP content varying between 10-20 wt.%. The monolithic 
glasses with TCP content ≥ 30 wt. % were prone to surface crystallization immediately after 
the casting of glass melts with FA as the primary crystalline phase. However, we could 
obtain glasses in frit form for compositions with TCP content varying between 10-40 wt.% 
(Fig. 3.1). The glass frits with TCP content > 40 wt.% were prone to severe devitrification 
immediately after casting of glass melt in cold water with FA as the primary crystalline 
phase as detected by XRD analysis. The retarding glass forming ability of the investigated 
system with decreasing Di/TCP ratio may be mainly attributed to the presence of FA in the 
glass compositions owing to its higher crystallization tendency. It is noteworthy that 
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Kamitakahara et al. [67] successfully synthesized glasses and glass-ceramics from 
composition 40 wt. % Di – 60 wt. % TCP.  
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Fig. 3.1. XRD of the TCP-series glasses 
3.1.3 Structure of glasses 
It has been well established that molecular structure of glasses plays a crucial 
role in deciding their bioactivity. For example: the high level of bioactivity in 45S5 
Bioglass® is known to arise from a structure dominated by chains of Q2 metasilicates, 
which are occasionally cross-linked through Q3 units, whereas Q1 species terminate the 
chains [68], where Qn species distribution furnishes a measure of the connectivity of the 
glass network and the index n refers to the number of bridging oxygens (BOs) 
surrounding a network former ions. Similarly, the enhanced dissolution of silica in 
highly bioactive compositions has also been found to be closely related to the 
significant fraction of Q1 (Si) chain terminators while moderate bioactivity can be 
achieved when Q3 (Si) structures predominate [68]. Therefore, understanding these 
features allows designing new glasses with improved chemical durability and tailored 
biodegradability for specific applications.  
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Fig. 3.2. Variation in peak positions of 29Si and 31P MAS-NMR spectra with respect to 
TCP content in glasses.  
 
The MAS-NMR results as presented in Fig. 3.2: the 29Si spectra for all the 
investigated glasses depict the dominance of Q2 (Si) structural units in the glasses [69]. 
In particular, the broad 29Si spectra for all the glasses implying towards a wider 
distribution Qn (Si) species in the glass structure. Further, although the amount of SiO2 
got decreased due to the introduction of TCP in the glasses (TCP: 10-40 wt.%), the 
centre of gravity of 29Si peaks shifted from ~ -80 pp for glass TCP-10 to ~ -83 for glass 
TCP-40, thus suggesting an increase in polymerization of the silicate glass network. The 
increasing polymerization of the silicate glass network, with increasing TCP content, is 
due to a significant increment in the amount of P2O5 in the glasses [69]. These results 
are in good agreement with the experimental evidence of Lockyer et al. [70] that was 
interpreted on the basis of higher affinity of alkali/alkaline-earth cations for phosphate 
groups, which are able to strip the modifier cations out of the silicate network, thus 
inducing re-polymerization. It is noteworthy that while molecular dynamic (MD) 
simulations do confirm the above discussed results, they also highlight an addition 
factor that leads to re-polymerization in silicate glass network due to addition of P2O5: 
phosphorus can replace Na+ or Ca2+ in balancing Si–NBO bonds.  
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Therefore, the silicate network re-polymerization can occur through either Si–
O–Si or Si–O–P new links. However, in the present case, we could not observe any 
significant change in peak maxima for spectra of 31P nucleus with predominance of an 
orthophosphate-type environment (Fig. 3.2). In fact, the observed chemical shifts, 1–2 
ppm, are close to that of the calcium orthophosphate (3.1 ppm) and that of the 
amorphous magnesium orthophosphate (ca. 0.5 ppm) [71]. Therefore, the possibility of 
formation of Si–O–P new links can probably be neglected. However, it should be noted 
that bioactivity is not solely a function of glass structure, but also depends on their 
chemical nature [72].   
According to Tilocca and Cormack [73], low fractions of P2O5 content in glasses 
(< 10 mol.%) enhances their bioactivity while further increase in P2O5 amount affects 
the bioactive nature of glasses in a negative manner. Similarly, according to Pariente et 
al. [74], the presence of Mg in phospho-silicate bioactive glasses increases the surface 
area and porosity, but retards the formation of an apatite layer on the glass surface in the 
in vitro tests, since Mg tends to associate preferentially with phosphorus at the glass 
surface, which consequently leads to a decrease in the apatite like-calcium phosphate 
concentration on the glass surface (that are suppose to act as nucleation centres for 
apatite formation). Therefore, in order to gain better insight about the bioactive nature 
of these glasses and draw structure-property relationship for this glass system, it is 
mandatory to investigate their in vitro/in vivo bioactive behaviour.  
 
3.1.4 Differential thermal analysis 
The DTA plots of fine powders with a heating rate (β) of 20 K min−1, shown in 
Fig. 3.3, feature an endothermic dip in the temperature interval of 750 – 755ºC 
corresponding to glass transition (Tg) before the onset of crystallization (Tc) followed by 
a well-defined single exothermic crystallization curve for glasses TCP-10, TCP-20 and 
TCP-30, respectively. We could not observe any significant differences in the variation 
of Tg values with varying Di/TCP ratio in the glasses.  
 
Further, the presence of single crystallization exotherm in the TCP-10 and TCP-
20 compositions anticipates that the glass-ceramic is formed either as a result of single 
phase crystallization or of an almost simultaneous precipitation of different crystalline. 
On the other hand, the TCP-40 compositions exhibits two crystallization peaks (Tp1 and 
Tp2) pointing towards the formation of two different crystalline phases. The TCP-30 
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composition shows a non-symmetrical exotherm that seems to results from the 
contribution of the two nucleation/crystallization events clearly declared in the TCP-40 
sample. 
It was observed that the peak temperature of crystallization (Tp) shifted to higher 
temperature with increasing heating rates (β). The Tp values for glasses TCP-10 and 
TCP-20 are almost similar (i.e. 932 ºC) while further decrease in Di/TCP ratio resulted 
in shifting of Tp to 907 ºC for glass TCP-30 and 843 ºC (Tp1) for glass TCP-40. This 
decrease in Tp values with increasing TCP content in glasses may be attributed to their 
increasing crystallization tendency as will be shown further in the section 3.1.5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3. DTA of glass powders at heating rate (β) of 20 K min−1 
 
3.1.5 Sintering and crystallization behaviour of glasses 
The requisite for optimizing the fabrication of glass-ceramic scaffolds is to 
understand the sintering conditions of glass powders and the interaction between 
sintering and crystallization of the material. By knowing the structural transformations 
which occur during the heat treatment of glasses, the scaffold fabrication process can be 
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tailored, e.g. in terms of achieving the highest possible density of the sintered scaffolds 
and the  required crystallinity which itself controls the material’s bioactivity [75]. It is 
due to this reason that a comparison between DTA and HSM thermographs obtained 
under same heating conditions can reveal a great deal of information in this regard.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.4. (a, b, c, & d) DTA and HSM thermographs of all the investigated glass 
compositions at β =5 K min-1. 
 
The glass-ceramic formation through glass powder involves the sintering of glass 
powders, followed by crystallization at a higher temperature. During the sintering of a 
glass powder compact with a size distribution of glass particles, small particles get 
sintered first as shown by Prado et al. [76]. 
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Fig. 3.5. Variation of different thermal parameters with composition 
 
Thus, sintering kinetics at first shrinkage (TFS) is dominated by the neck 
formation among smallest particles by viscous flow and is best described by the Frenkel 
model of sintering [77]. Maximum shrinkage (TMS) is reached when larger pores (pores 
formed from cavities among larger particles) have disappeared due to viscous flow that 
reduces their radii with time. This region of sintering kinetics may be described by the 
Mackenzie-Shuttleworth model of sintering [78]. However, various physical processes 
(entrapped insoluble gases, crystallization) occurring at the very end of sintering process 
might affect the densification kinetics.  
  
 In general, two different trends can be observed related to the sintering and 
crystallization behaviour of the glasses: (i) the onset of crystallization (Tc) occur after 
the final sintering stage. Thus, under such circumstances, sintering and crystallization 
are independent processes. This is the required trait to obtain well sintered glass-
ceramic scaffolds with good mechanical properties; (ii) Tc appears before maximum 
density has been reached. In this case, the crystallization process starts before complete 
densification, thus, preventing further sintering. In the present study both of the above 
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mentioned trends related with sintering and crystallization behaviour of glasses have 
been observed depending on the glass compositions. Fig. 3.4 (a, b, c, & d) presents the 
DTA and HSM thermographs of all the investigated glass compositions at β =5 K min-1. 
As is evident from Fig. 3.4 (a, b, c, & d), all the glass compositions exhibit a single 
stage sintering behaviour. Fig. 3.5 presents variation in different thermal parameters 
with respect to variation in TCP content in glasses. The values for TFS (log η = 9.1 ± 
0.1, η is viscosity; dPa s) and TMS (log η = 7.8 ± 0.1) exhibited a slight decrease with 
increasing TCP content in glasses while values for Tc showed an initial increase and 
then a steep decrease with decreasing Di/TCP ratio (Fig. 3.5).  
 
With respect to TMS and Tc, different trends were observed for the investigated 
glass compositions which can be explained with the aid of sinterability parameter (Sc), 
where Sc = Tc - TMS. The parameter Sc is the measure of ability of sintering versus 
crystallization: the greater this difference, the more independent are the kinetics of both 
processes [79]. The estimated error for data points is smaller than ± 10%, approximately 
equal to the size of the data symbols. As can be seen from Fig. 3.5, the value of 
parameter Sc increased with increasing TCP content in the glasses until TCP = 20 wt.%. 
However, further decrease in Di/TCP ratio led to a gradual decrease in the value of Sc 
with glass TCP-40 (Sc = - 24ºC) exhibiting the lowest value for Sc. These results imply 
that sintering precedes crystallization in glass compositions TCP-10, TCP-20 and TCP-
30 with glass composition TCP-20 exhibiting the superior sintering ability in 
comparison to the other investigated compositions. Therefore, we can expect well 
sintered, dense and mechanically stronger glass-ceramics from composition TCP-20 in 
comparison to its counterparts. On the other hand, crystallization precedes sintering in 
glass TCP-40 which should result in a poorly sintered and mechanically weak glass-
ceramic material. 
 
Fig. 3.6 presents the photomicrographs as obtained from HSM exhibiting the 
changes in the geometric shape of the glass powder compacts with respect to 
temperature. As is evident from Fig. 3.6, the softening or deformation temperature of 
glass powder compacts decreased considerably with increasing TCP content in glasses 
until 30 wt.%.  
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Fig. 3.6. HSM images of glasses at various stages of heating cycle. 
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The deformation temperature is the point at which the first signs of softening are 
observed. This is generally shown by the disappearance or rounding of the small 
protrusions at the edges of the sample (log η = 6.3 ± 0.1). The value of deformation 
temperature increased significantly for glass composition TCP-40 owing to its high 
refractoriness due to severe crystallization. Further, the half-ball or hemisphere 
temperature (i.e. the temperature at which the section of the sample observed forms a 
semicircle on the microscope grid; log η = 4.1 ± 0.1) and flow temperature (i.e. the 
temperature at which the maximum height of the drop of the molten glass corresponds 
to a unit on the microscopic scale; log η = 3.4 ± 0.1) decreased slightly with increase in 
TCP content in glasses. 
Fig. 3.7 presents the SEM images of the glass powder compacts after sintering in 
temperature interval of 800-900 ºC for 1 h. In agreement with HSM and DTA results, 
the sintering of glass powder compacts at 800 ºC resulted in well sintered and dense 
glass-powder compacts for compositions TCP-10 (Fig. 3.7a), TCP-20 (Fig. 3.7b) and 
TCP-30 (Fig. 3.7c), respectively while TCP-40 resulted in a poorly sintered and 
mechanically weak glass powder compact. The flexural strength values as obtained for 
composition TCP-20 sintered at 800 and 850 ºC are 85 ± 6 MPa and 127 ± 9 MPa, 
respectively.  
  
 
  
 
 31 
 
 
Fig. 3.7. SEM images of the TCP glass powder compacts after sintering in temperature 
interval of 800-900 ºC for 1 h. 
The qualitative crystalline phase analysis of sintered glass powders as presented 
in Fig. 3.8a revealed that compositions TCP-10 and TCP-20 were completely 
amorphous after sintering at 800 ºC while FA (ICDD card: 71-880) precipitated as the 
major crystalline phase in compositions TCP-30 and TCP-40 along with Di (ICDD 
card: 78-1390) and the intensity of XRD peaks increased with increasing TCP content 
in glasses, thus, indicating an increase in crystallinity (Fig. 3.8a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.8. XRD of qualitative crystalline phase analysis of sintered glass powders  
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These results are in co-relation with the microstructural evolution of sintered 
glass-ceramics as studied through SEM. Fig. 3.7c depicts the formation of crystals 
beneath the amorphous layer in composition TCP-30, thus depicting the presence of 
crystallinity. Further increase in sintering temperature to 800 ºC (Fig. 3.8a) and 850 ºC 
(Fig. 3.8b) resulted in appearance of crystallinity in all the investigated glass 
compositions with Di as the major crystalline phase in compositions TCP-10 and TCP-
20, thus rendering them good sintering ability while FA dominated the crystalline phase 
assemblage in compositions TCP-30 and TCP-40, thus leading to their poor sintering 
ability. The SEM images (Fig. 3.7d and 3.7e) obtained from GC TCP-10 after sintering 
at 900 ºC depict the presence of thin lamellar crystals typical for diopside intermixed 
with needle like fluorapatite crystals (Fig. 3.7e). The results obtained in the present 
study are different from those obtained by Kamitakahara et al. [67] in their study related 
with synthesis of glass-ceramics in Di-TCP binary system and also from the results of 
Magallanes-Perdomo et al. [80] where they investigated the devitrification behaviour of 
a eutectic glass-ceramic composition in wollastonite-TCP binary system as in both the 
earlier studies, TCP crystallized in glass-ceramics the form of α- [15] or β-TCP [2] 
along with other crystalline phases. However, in the present study, no trace of 
crystallization of TCP has been observed, as its growth seems to be masked by FA. 
 
3.2. Influence of Sr-doping on the structure and thermophysical properties of 
alkali-free phosphosilicate glasses 
 
3.2.1 Design of glass compositions 
 
The choice of the parent glass composition in this study was made on the basis 
of results obtained in the section 3.1 dealing with synthesis and characterization of 
glasses and glass-ceramic in Di-FA-TCP system. The theoretical composition of 
selected parent glass is 70 Di – 10 FA- 20 TCP (wt.%). Further, partial substitution of 
SrO for CaO (0 – 10 mol.%) has been made taking into account the beneficial aspects of 
Sr containing biomedical implants as discussed in Chapter 1 (State of the Art). Table 
3.2.1 presents the detailed compositions of the glasses investigated.  
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Table 3.2.1: Composition of SrO containing glasses 
Glass MgO CaO SrO P2O5 SiO2 CaF2 
Sr-2 19.24 34.07 2 5.61 38.49 0.59 
Sr-4 19.24 32.07 4 5.61 38.49 0.59 
Sr-6 19.24 30.07 6 5.61 38.49 0.59 
Sr-8 19.24 28.07 8 5.61 38.49 0.59 
Sr-10 19.24 26.07 10 5.61 38.49 0.59 
 
 
 3.2.2 Glass forming ability 
Melting at 1550 ºC for 1 h was adequate to obtain highly homogenous molten 
glasses for all the investigated compositions, which, after casting, resulted in bubble-
free, homogenous, transparent glasses. The absence of crystalline inclusions was 
confirmed by XRD and SEM analyses. 
 
3.2.3 Density of glasses 
The experimental results as presented in Fig. 4.2.1 showed that the partial 
substitution of CaO by SrO led to an increase in the density (ρ) of the selected parent 
glass (Fig. 4.2.1). Since, density of a glass is an additive property and density of SrO 
(ρ = 5.10 g cm−3) is higher than CaO (ρ = 3.34 g cm−3), therefore, an increase in density 
with increasing SrO/CaO ratio contents is logical.  
 
 
 
 
 
 
 
 
 
 Fig. 3.2.1. Evolution of density (ρ) as a function of the Sr content in glasses. 
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3.2.4 Structure of glasses 
 
The room temperature FTIR transmittance spectra of all the investigated glasses 
are shown in Fig. 3.2.2 while the MAS NMR spectra of selected glasses for 29Si and 31P 
nuclei are presented in Fig. 3.2.3a and 3.2.3b, respectively. In general, the IR spectra of 
all the investigated glasses exhibit three broad transmittance bands in the region of 300–
1300 cm−1. This lack of sharp features is indicative of the general disorder in the silicate 
and phosphate network mainly due to a wide distribution of Qn (polymerization in the 
glass structure, where n denotes the number of bridging oxygens) units occurring in 
these glasses. 
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Fig. 3.2.2. FTIR Spectra of Sr-containing glasses  
 
The most intense bands in the 800–1300 cm−1 region correspond to the 
stretching vibrations of the SiO4 tetrahedron with a different number of bridging 
Oxygen atoms [81]. It should be noted that the band near ~1045 cm−1 may also be 
attributed to PO3 end groups due to the presence of P2O5 glass network former in the 
investigated glasses [82]. Similarly, transmittance bands near 920 cm−1 may be 
attributed to the polymerization in silicate network structure with two bridging oxygens 
(Q2 units) [81] and [83] along with some Q1 units.  
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The FTIR results are in good agreement with the NMR results presented in Fig. 
3.2.3. The peaks of 29Si spectra for all the investigated glasses (Fig. 3.2.3a) depict the 
dominance of Q2 (Si) structural units in the glasses [84] while 31P NMR spectra for 
these glasses (Fig. 3.2.3b) reveal the formation of calcium orthophosphate groups in the 
glasses. 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
Fig. 3.2.3a. 29Si MAS-NMR of glasses Sr-4 and Sr-8 glasses. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.3b. 31P MAS-NMR of glasses Sr-4 and Sr-8 glasses. 
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3.2.5 Thermal behaviour of glasses 
The CTE values as obtained from dilatometry in the temperature interval of 200 
– 500ºC varied between (10.6 – 11.4) x 10-6 K-1. However, we could not obtain a 
particular trend in the variation of CTE values for these glasses.  The Fig. 3.2.4 presents 
the TA thermographs of the investigated glasses at β = 10 K min-1.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.4. DTA thermographs of the investigated Sr- containing glasses at β = 10 K min-1  
 The variation in SrO/CaO ratio in glasses did not exhibit any significant 
influence on value of glass transition temperature (Tg) (as obtained from the mid-point 
of endothermic dip before onset of crystallization in DTA thermograph) as it varies in 
the range 740-743 ºC for the studied glasses. Further, the presence of single 
crystallization exotherm anticipates that the glass-ceramic is formed either as a result of 
single phase crystallization or of an almost simultaneous precipitation of different 
crystalline phases. A gradual decrease in intensity of the exothermic peaks and a shift of 
Tp values to higher temperatures could be observed with increasing SrO content in the 
glasses. This means that the sinterability parameter is enhanced, while the trend to 
crystallization is depressed with increasing SrO content. These variations in DTA 
thermographs and their implications in the sintering/crystallization behaviour are 
consistent with a decreased diffusivity of the larger ionic radius Sr2+ (1.18 Å) in 
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comparison to that of Ca2+ (1.00 Å), therefore stabilizing the glassy phase. These results 
are slightly different from the results of Fredholm et al. [85] where it has been shown 
that Tg and Tp decrease with increase in SrO content in the phosphosilicate glasses. 
These differences in results can be attributed to the different structural environment as 
well as nature of crystalline phases precipitated in the glasses investigated in these 
studies. 
Fig. 3.2.5 (a, b, c, d & e) presents the DTA and HSM thermographs of all the 
investigated glass compositions at β =5 K min-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.5. DTA and HSM thermographs of 
all the investigated Sr-containing glass 
compositions at β =5 K min-1: (a) Sr-2; (b) 
Sr-4; (c) Sr-6; (d) Sr-8; & (e) Sr-10. 
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As is evident from Fig. 3.2.5, all the glass compositions exhibit a single stage sintering 
behaviour.  
 
Fig. 3.2.6 presents variation in different thermal parameters with respect to variation in 
SrO content in glasses. The values for TFS (log η = 9.1 ± 0.1, η is viscosity; dPa s) and 
TMS (log η = 7.8 ± 0.1) exhibited a slight decrease with increasing SrO content in 
glasses while values for Tc showed a gradual increase with decreasing CaO/SrO ratio 
(Fig. 3.2.6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.6. Variation in different thermal parameters with respect to variation in SrO 
content in glasses. 
 
From this figure, it can be seen that the sinterability parameter (Sc), where Sc = 
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decrease for the sample Sr-10. This apparent decrease contradicts the DTA results 
plotted in Fig. 3.2.4). It is worth noting that the reliability of DTA results is expected to 
be higher since it is less operator dependent in comparison to the thermal parameters 
data gathered from the HSM. The increase of the sinterability parameter with the 
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DTA results reported in Fig. 3.2.4, one could also admit that this favourable trend 
should also be expected for the Sr-10 composition. Therefore, we can expect well 
sintered, dense and mechanically stronger glass-ceramics from all the compositions. 
The above discussed HSM and DTA results are in good agreement with the 
results obtained after sintering of glass powder compacts at 850ºC for 1 h. The sintering 
of glass powder compacts at 850ºC resulted in well sintered and dense glass-powder 
compacts for all the compositions as is evident from the SEM images of the un-polished 
sintered glass-ceramics shown in Fig. 3.2.7 (a, b, c & d). 
  
 
 
  
 
 
 
 
 
Fig. 3.2.7. SEM microstructures (revealed via chemical etching) of GCs heat treated at 
850ºC at 1 h: (a) Sr-2; (b) Sr-4. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.7 (c) (d) Microstructure (Revealed via SEM imaging after chemical etching) of 
GCs (c) Sr-8 and (d) Sr-8 SEM images heat treated at 850ºC at 1 h, respectively. 
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It should be mentioned here that small fractions of closed porosity were 
observed in some of sintered glass powder compacts (Fig. 3.2.7c)  which is a usual 
phenomenon [86]. The qualitative crystalline phase analysis of sintered glass powders 
revealed that Di (ICDD card: 78-1390) along with FA (ICDD card: 71-880) precipitated 
as the only crystalline phases in all the investigated compositions (Fig. 3.2.8). The 
overall amount of crystalline phases, as evaluated from the intensity of XRD peaks, 
tends to decrease with increase in SrO content in glasses, which is consistent with the 
thermal behaviour of the glasses discussed above (page 38). But SrO exerts opposite 
effects on the crystallization extent of Di and FA. Di is the major crystalline phase in 
glass-ceramics with lower SrO contents (0 – 2 mol.%) but its amount clearly decreases 
along the whole range of SrO additions; while the gradual increment in SrO/CaO ratio 
initially enhanced the crystallization of FA followed by a decreasing trend. It is 
noteworthy that we could not detect any SrO-containing crystalline phase in any of the 
investigated glass-ceramic compositions. Therefore, we can presume that either the Sr2+ 
ions are being preferentially accommodated in FA crystal structure or tend to remain in 
amorphous glassy phase, or both. Thus, it will be crucial to make Rietveld analysis on 
these glass-ceramics in order to get better insight about the position of Sr2+ in the 
investigated systems.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.8. XRD patterns of the Sr-containing glass powder compacts after sintering at 
850ºC for 1 h.  
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3.3 Influence of Zn-doping on structure and thermophysical properties of alkali-
free phosphosilicate glasses 
 
3.3.1 Design of glass compositions 
 
The choice of parent glass composition in this study was made on the basis of 
results obtained in our previous study dealing with synthesis and characterization of 
glasses and glass-ceramic in Di-FA-TCP system. The theoretical composition of 
selected parent glass is 70 Di – 10 FA- 20 TCP (wt.%). Further, partial substitution of 
ZnO for MgO (0 – 10 mol.%) has been made on mole percentage. Table. 3.3.1 presents 
the detailed compositions of the glasses investigated in present study.  
 
 
Table 3.3.1. Compositions of ZnO-containing glasses 
Glass MgO ZnO  CaO  P2O5 SiO2 CaF2 
Zn-2 17.24 2  36.07 5.61 38.49 0.59 
Zn-4 15.24 4  36.07 5.61 38.49 0.59 
Zn-6 13.24 6  36.07 5.61 38.49 0.59 
Zn-8 11.24 8  36.07 5.61 38.49 0.59 
Zn-10 9.24 10  36.07 5.61 38.49 0.59 
 
 
3.3.2 Glass forming ability 
 
Melting at 1550ºC for 1 h was adequate to obtain highly homogenous molten 
glasses for all the investigated compositions, which, after casting, resulted in bubble-
free, homogenous, transparent glasses. The absence of crystalline inclusions was 
confirmed by XRD analyses. 
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3.3.3 Structure of glasses 
 
The room temperature FTIR transmittance spectra of all the investigated glasses 
are shown in Fig. 3.3.1 while the MAS NMR spectra of selected glasses for 29Si and 31P 
nuclei are presented in Fig. 3.3.2, respectively. In general, the IR spectra of all the 
investigated glasses exhibit three broad transmittance bands in the region of 300–
950 cm−1. This lack of sharp features is indicative of the general disorder in the silicate 
and phosphate network mainly du e to a wide distribution of Qn (polymerization in the 
glass structure, where n denotes the number of bridging oxygens) units occurring in 
these glasses. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3.1. FTIR Spectra of Zn-containing glasses 
 
The most intense bands in the 750–950 cm−1 regions correspond to the stretching 
vibrations of the SiO4 tetrahedron with a different number of bridging Oxygen atoms 
[87]. It should be noted that the band near ~920 cm−1 may also be attributed to PO3 end 
groups due to the presence of P2O5 glass network former in the investigated glasses 
[88]. Similarly, transmittance bands near 930 cm−1 may be attributed to the 
polymerization in silicate network structure with two bridging oxygens (Q2 units) [87] 
and [89] along with some Q1 units. The FTIR results are in good agreement with the 
NMR results presented in Fig. 3.3.2. The peaks of 29Si spectra for all the investigated 
glasses depict the dominance of Q2 (Si) structural units in the glasses [90] while 31P 
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NMR spectra for these glasses reveals the formation of calcium orthophosphate groups 
in the glasses.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3.2. Variation in peak positions of 29Si and 31P MAS-NMR spectra with 
respect to Zn content in glasses.  
 
 
 
3.3.4 Thermal behaviour of glasses  
 
Fig. 3.3.3 (a, b, c, d & e) presents the DTA and HSM thermographs of all the 
investigated glass compositions at β =5 K min-1. As is evident from Fig. 3.3.3, all the 
glass compositions exhibit a single stage sintering behaviour. Fig. 3.3.4 presents 
variation in different thermal parameters with respect to variation in ZnO content in 
glasses. The values for TFS (log η = 9.1 ± 0.1, η is viscosity; dPa s) and TMS (log η = 7.8 
± 0.1) exhibited a abrupt change in the values with respect to the ZnO content in glasses 
while values for Tc showed a gradual decrease with decreasing MgO/ZnO ratio (Fig. 
3.3.4). With respect to sinterability parameter (Sc), defined as Sc = Tc - TMS, somewhat 
abrupt and non-monotonous changes are observed with the gradual increase in ZnO 
content in the glasses (Fig. 3.3.4). 
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Fig: 3.3.3. DTA and HSM thermographs of all the investigated glass compositions at β 
=5 K min-1: (a) Zn-2; (b) Zn-4; (c) Zn-6; (d) Zn-8; & (e) Zn-10 
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Fig. 3.3.4. Variation in different thermal parameters with respect to variation in 
ZnO content in glasses (DTA of Zn-2 is not available). 
 
 
These results should be regarded with some care since the determination of 
thermal parameters might be somewhat operator dependent. But for all these 
compositions, sintering precedes crystallisation and the glasses exhibit single stage 
sintering behaviour. As can be seen from Fig. 3.3.4, the value of parameter Sc decreased 
gradually with increasing ZnO content in the glasses until Zn-6. However, further 
increase of ZnO/MgO ratio led to a increase in the value of Sc with glass Zn-8 (Sc = 
37ºC) exhibiting the Sc value almost equal to that of Zn-4 (Sc = 40ºC). All these ZnO 
based glasses exhibits superior sintering ability in comparison to the least sinterability 
Sc value being the glass Zn-10 (Sc=11ºC). Therefore, we can expect well sintered, dense 
and mechanically stronger glass-ceramics from these ZnO containing glass 
compositions.  
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Fig. 3.3.5. XRD patterns for glass powder compacts after sintering at 850ºC for 1 h. 
 
Figure 3.3.5 shows the XRD patterns for glass powder compacts after sintering at 
850ºC for 1 h. The qualitative crystalline phase analysis of sintered glass powders 
revealed that Di (ICDD card: 78-1390) along with FA (ICDD card: 74-4390) precipitated 
as the only crystalline phases in all the investigated compositions (Fig. 3.3.5). The 
amount of crystalline phases, as evaluated from the intensity of XRD peaks, varied with 
increase in ZnO content in glasses.. There seems to be an overall increasing trend of the 
total amount of crystalline phases, as well as of the amounts of each individual phase. 
This is probably due to an enhanced diffusivity of the ionic species favoured by an 
eventual decrease of the melt viscosity with increasing added amounts of ZnO.  
It is noteworthy that we could not detect any ZnO-containing crystalline phase in 
any of the investigated glass-ceramic compositions. Therefore, we can presume that either 
the Zn2+ are being accommodated either in Di or FA crystal structure or tend to remain in 
amorphous glassy phase. This is not surprising considering that the ionic radius of 
substituting Zn2+ (0.74 Å) is very similar to that of Mg2+ (0.72 Å). To shed further light 
on this issue, it will be crucial to make Rietveld analysis on these glass-ceramics in order 
to get better insight about the position of Zn2+ in the investigated systems. 
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Chapter 4 
Conclusions 
 
 
 
 48 
An insight into the structure, sintering and crystallization behaviour of 
potentially bioactive glasses in Di-FA-TCP system has been presented. Also, the 
influence of varying SrO/CaO and ZnO/MgO ratios on various thermo-physical 
properties of the parent glass system has been investigated. The following conclusions 
can be drawn from the present work: 
i) Amorphous glasses could be obtained only for compositions with TCP ≤ 40 
wt.%.  
ii) The structure of the investigated glasses have some peculiar similarities with the 
structure of 45S5 glass since the Qn (Si) units are dominated by Q2 and Q3 units 
while phosphate is predominantly in orthophosphate type environment.  
iii) The variation in TCP content in glasses or varying CaO/SrO ratio did not 
significant affect the glass transition temperature. 
iv) A single step sintering behaviour was exhibited by all the investigated glass 
compositions. The increase in TCP content in glasses improved the sintering 
ability of glasses until TCP ≤ 20 wt.%. An increase in TCP content beyond this 
limit led to a gradual degradation in sintering behaviour of glass powders, thus 
rendering mechanically weak glass-ceramics.  
v) On the other hand, an increase in SrO content in glasses at the expense of CaO 
led to an improvement in sintering behaviour of glasses as depicted by a gradual 
increase in the difference Tc – Tg as deduced from DTA analysis, also partially 
confirmed by the HSM data. While an increase in ZnO content in glasses at the 
expense of MgO shows an apparent abrupt and non-monotonous change in the 
Sc values as determined by HSM. 
vi) All the Sr- and Zn-doped glasses exhibit a structure dominated by Q2 (Si) units 
while phosphorus coordinates predominantly in orthophosphate environment. 
An increase in Sr2+/Ca2+ and Zn2+/Mg2+ ratio did not affect the glass structure 
significantly. The CTE of glasses did not depict any particular variation trend 
with increasing strontium/zinc content in glasses while their Tg remained almost 
constant. 
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vii) Di and FA crystallized as the only crystalline phases in all the glass-ceramics. It 
is noteworthy that we could not detect any SrO/ZnO containing crystalline phase 
in any of the investigated glass-ceramic compositions. We can presume that 
either the Sr2+/Zn2+ are being accommodated either in Di or FA crystal structure 
or tend to remain in amorphous glassy phase. However it is noteworthy that 
Rietveld refinement studies are crucial in order to determine the quantitative 
analysis and to get better insight about the position of Sr2+/Zn2+ in the 
investigated systems. 
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Future  
Directions 
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1. The influence of various functional ions (for example: Ag+, Cu+, etc.) 
should be investigated on the structure, and thermal properties of the 
parent glass system. 
2. In vitro bioactivity analysis, i.e., immersion of glasses in simulated body 
fluid (SBF) should be evaluated in order to understand the biological 
potential of these glasses. 
3. Physico-chemical degradation of glasses should be evaluated in Tris-HCl 
and citric acid buffer in accordance with ISO 10993-14 standard.  
4. An emphasis should be made on the quantitative crystalline/amorphous 
phase evolution from XRD data in glass-ceramics using Rietveld 
refinement technique. 
5. Mechanical strength measurements including flexural strength, 
microhardness and elastic properties should be measured on the 
synthesized glass-ceramics. 
6. As synthesized glass-ceramics should be evaluated for their biological 
potential in vitro as well as in vivo. 
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